Literature DB >> 12200799

Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy.

Scott G Satko1, Carl D Langefeld, Pirouz Daeihagh, Donald W Bowden, Stephen S Rich, Barry I Freedman.   

Abstract

BACKGROUND: The prevalence of abnormal proteinuria and elevated serum creatinine (sCr) concentrations in diabetic sibs of African Americans (AAs) with overt type 2 diabetic nephropathy (DN) or end-stage renal disease (ESRD) is unknown.
METHODS: We measured urine albumin-creatinine (UAC) ratio, sCr, and hemoglobin A1c (HbA1c) in 211 sibs from 66 families (66 unrelated index cases with overt type 2 DN/ESRD, 132 of their diabetic sibs, and 13 of their nondiabetic sibs). Overt DN was defined as a UAC ratio of 1,000 mg/g or greater or ESRD attributed to diabetes. All index cases had at least one diabetic sib screened.
RESULTS: Given similar mean ages and body mass indices, nondiabetic sibs had lower UAC ratios and HbA1c values compared with diabetic sibs and index cases (Wilcoxon's rank-sum test, all P < 0.006). More than 60% of index cases had at least one diabetic sib with a UAC ratio of 30 or greater and 300 mg/g or less. Nearly 35% of index cases had at least one sib with a UAC ratio greater than 300 mg/g. Nearly 24% of index cases had at least one sib with an elevated sCr level (> or =1.4 mg/dL [124 micromol/L] in women, > or =1.6 mg/dL [141 micromol/L] in men).
CONCLUSION: Asymptomatic elevations in urinary albumin excretion and sCr levels are frequently present in diabetic sibs of AA individuals with overt type 2 DN. Diabetic sibs of AA individuals with type 2 DN should be the focus of intensive screening and intervention programs to slow the current epidemic of diabetic ESRD. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200799     DOI: 10.1053/ajkd.2002.34888

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Prevalence and risk factors of diabetic nephropathy in omani type 2 diabetics in Al-dakhiliyah region.

Authors:  Abdulhakeem Hamood Alrawahi; Syed Gauhar A Rizvi; Dawood Al-Riyami; Zaher Al-Anqoodi
Journal:  Oman Med J       Date:  2012-05

Review 2.  Diabetic nephropathy in African-American patients.

Authors:  Errol D Crook; Sejal R Patel
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

3.  Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.

Authors:  Susan B Gurley; Carrie L Mach; Johannes Stegbauer; Jihong Yang; Kamie P Snow; Ann Hu; Timothy W Meyer; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-30

Review 4.  Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 5.  Inhibition of RAS in diabetic nephropathy.

Authors:  Rabi Yacoub; Kirk N Campbell
Journal:  Int J Nephrol Renovasc Dis       Date:  2015-04-15

6.  Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes.

Authors:  Mohammad Fathi; Abdol Rahim Nikzamir; Alireza Esteghamati; Manouchehr Nakhjavani; Mir Saeed Yekaninejad
Journal:  Iran Red Crescent Med J       Date:  2015-02-21       Impact factor: 0.611

Review 7.  Diabetic nephropathy - complications and treatment.

Authors:  Andy Kh Lim
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-10-15

8.  Undiagnosed Kidney Injury in Uninsured and Underinsured Diabetic African American Men and Putative Role of Meprin Metalloproteases in Diabetic Nephropathy.

Authors:  Lei Cao; Rashin Sedighi; Ava Boston; Lakmini Premadasa; Jamilla Pinder; George E Crawford; Olugbemiga E Jegede; Scott H Harrison; Robert H Newman; Elimelda Moige Ongeri
Journal:  Int J Nephrol       Date:  2018-04-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.